NZís Pharmac Under the Cosh for Rushing Through Approval of Anti-Blood Clotting Drug

by Kathy Jones on  September 12, 2011 at 7:21 PM General Health News
RSS Email Print This Page Comment
New Zealand's drug regulatory agency, Pharmac was accused of rushing drugs on to the market following the death of at least two people after taking an anti-blood clotting drug.
 NZís Pharmac Under the Cosh for Rushing Through Approval of Anti-Blood Clotting Drug
NZís Pharmac Under the Cosh for Rushing Through Approval of Anti-Blood Clotting Drug
Advertisement

Apart from the two deaths, the Centre for Adverse Reactions Monitoring (Carm) has also received more than 50 reports of bleeding among those who had taken the blood thinning drug, Pradaxa.

Advertisement
Some of the leading doctors in the country accused Pharmac of rushing the drug to the market even before finding how to manage its side effects.

Says Humphrey Pullon, of the Haematology Society, "We do have concerns about the way it was rolled out. It was rolled out very rapidly without a lot of forethought and planning. In particular the fact that general practitioners could have widespread access to this drug from day one was a concern to us, when some of them did not know how to use it."



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive